Amarin | 营业费用

Operating Expenses 更改 日
AbbVie USD 11.11B 540M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amarin USD 87.51M 16.62M 2023-09
AstraZeneca USD 9.54B 578M 2023-09
BioCryst Pharmaceuticals USD 98.66M 33.55M 2023-09
Esperion Therapeutics USD 61.5M 1.34M 2023-09
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Halozyme Therapeutics USD 129M 1.25M 2023-12
Heron Therapeutics USD 56.36M 17.8M 2023-09
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Nektar Therapeutics USD 69.01M 2.09M 2023-09
Neurocrine Biosciences USD 357.6M 21.5M 2023-09



Amarin 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.